Academic Bibliography

Show Sort by

Your filters: cql: parent exact "CLINICAL PHARMACOKINETICS"

Mark
A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients

Huybrecht T'jollyn (UGent) , An Vermeulen (UGent) , Jan Van Bocxlaer (UGent) and Pieter Colin (UGent)

(2018) CLINICAL PHARMACOKINETICS. 57(1). p.59-69
Mark
Scientific rationale for determining the bioequivalence of inhaled drugs

Omar S Usmani, Mathieu Molimard, Vaibhav Gaur, Jaideep Gogtay, Gur Jai Pal Singh, Geena Malhotra and Eric Derom (UGent)

(2017) CLINICAL PHARMACOKINETICS. 56(10). p.1139-1154
Mark
- journalArticle
- A1
- open access
Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine

Maud AS Weerink, Michel Struys (UGent) , Laura N Hannivoort, Clemens RM Barends, Anthony R Absalom and Pieter Colin (UGent)

(2017) CLINICAL PHARMACOKINETICS. 56(8). p.893-913
Mark
- journalArticle
- A1
Population pharmacokinetic modeling of canagliflozin in healthy volunteers and patients with type 2 diabetes mellitus

Eef Hoeben, Willem De Winter, Martine Neyens, Damayanthi Devineni, An Vermeulen (UGent) and Adrian Dunne

(2016) CLINICAL PHARMACOKINETICS. 55(2). p.209-223
Mark
- journalArticle
- A1
- open access
Alternative sampling strategies for cytochrome P450 phenotyping

Pieter De Kesel (UGent) , Willy Lambert (UGent) and Christophe Stove (UGent)

(2016) CLINICAL PHARMACOKINETICS. 55(2). p.169-184
Mark
- journalArticle
- A1
- open access
Effects of food and pharmaceutical formulation on desmopressin pharmacokinetics in children

Robin Michelet (UGent) , Lien Dossche (UGent) , Pauline De Bruyne (UGent) , Pieter Colin (UGent) , Koen Boussery (UGent) , Johan Vande Walle (UGent) , Jan Van Bocxlaer (UGent) and An Vermeulen (UGent)

(2016) CLINICAL PHARMACOKINETICS. 55(9). p.1159-1170
Mark
The effect of weight and CYP3A5 genotype on the population pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients

Agnieszka Prytula-Ebels (UGent) , Karlien Cransberg, Antonia HM Bouts, Ron HN van Schaik, Huib de Jong, Saskia N de Wildt and Ron AA Mathot

(2016) CLINICAL PHARMACOKINETICS. 55(9). p.1129-1143
Mark
Propofol breath monitoring as a potential tool to improve the prediction of intraoperative plasma concentrations

Pieter Colin, Douglas J Eleveld, Johannes P van den Berg, Hugo EM Vereecke, Michel Struys (UGent) , Gustav Schelling, Chrisitan C Apfel and Cyrill Hornuss

(2016) CLINICAL PHARMACOKINETICS. 55(7). p.849-859
Mark
- journalArticle
- A1
- open access
Paraxanthine/caffeine concentration ratios in hair: an alternative for plasma-based phenotyping of cytochrome P450 1A2?

Pieter De Kesel (UGent) , Willy Lambert (UGent) and Christophe Stove (UGent)

(2015) CLINICAL PHARMACOKINETICS. 54(7). p.771-781
Mark
- journalArticle
- A1
- open access
Why dried blood spots are an ideal tool for CYP1A2 phenotyping

Pieter De Kesel (UGent) , Willy Lambert (UGent) and Christophe Stove (UGent)

(2014) CLINICAL PHARMACOKINETICS. 53(8). p.763-771

Academic Bibliography

A physiologically based pharmacokinetic perspective on the clinical utility of albumin-based dose adjustments in critically ill patients

Scientific rationale for determining the bioequivalence of inhaled drugs

Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine

Population pharmacokinetic modeling of canagliflozin in healthy volunteers and patients with type 2 diabetes mellitus

Alternative sampling strategies for cytochrome P450 phenotyping

Effects of food and pharmaceutical formulation on desmopressin pharmacokinetics in children

The effect of weight and CYP3A5 genotype on the population pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients

Propofol breath monitoring as a potential tool to improve the prediction of intraoperative plasma concentrations

Paraxanthine/caffeine concentration ratios in hair: an alternative for plasma-based phenotyping of cytochrome P450 1A2?

Why dried blood spots are an ideal tool for CYP1A2 phenotyping

Contents

Support

Contact